// App-Quantinova.ai

: Rituximab as Treatment of Chronic Idiopathic Urticaria

Researchers

Presenter

  • Saira Zafar

Principal Investigators

  • Mark Weinstein

  • Alan Wolff

Medical Centers

  • Rutgers NJMS

  • Hudson-Essex Allergy, LLC

  • Department of Veterans...

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

  • Autoimmune (AI)

  • Musculoskeletal

  • Dermatology

  • Central Nervous System (CNS)

Disease

  • Common variable immunodeficiency

  • Autoimmune Thyroid Disease

  • Psoriatic arthritis

  • Multiple Sclerosis

  • Allergic rhinitis

  • Atopic Dermatitis

  • Inflammatory Arthritis

Biomarkers

  • N/A

Drug/Treatment

  • Mycophenolate mofetil

  • CKD-4101

  • Hydroxychloroquine

  • Immune globulin

  • Mycophenolic acid

  • Cyclosporine eent

  • Omalizumab

  • Prednisone

  • Rituximab

  • Dapsone

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved